학술논문

Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer
Document Type
Article
Source
In Clinical Breast Cancer December 2022 22(8):792-800
Subject
Language
ISSN
1526-8209